Applications of iPSC-derived models of Gaucher disease.
作者信息
Borger Daniel K, Aflaki Elma, Sidransky Ellen
机构信息
Section of Molecular Neurogenetics, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Ann Transl Med. 2015 Nov;3(19):295. doi: 10.3978/j.issn.2305-5839.2015.10.41.
Abstract
摘要
相似文献
1
Applications of iPSC-derived models of Gaucher disease.诱导多能干细胞衍生的戈谢病模型的应用。
Ann Transl Med. 2015 Nov;3(19):295. doi: 10.3978/j.issn.2305-5839.2015.10.41.
2
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism.一种新型葡萄糖脑苷脂酶伴侣可降低戈谢病和帕金森综合征患者诱导多能干细胞衍生的多巴胺能神经元中的α-突触核蛋白和糖脂水平。
J Neurosci. 2016 Jul 13;36(28):7441-52. doi: 10.1523/JNEUROSCI.0636-16.2016.
3
Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells.戈谢病诱导多能干细胞衍生神经元细胞中TFEB介导的溶酶体生物合成改变。
Hum Mol Genet. 2015 Oct 15;24(20):5775-88. doi: 10.1093/hmg/ddv297. Epub 2015 Jul 28.
4
Generation of two iPSC lines derived from two unrelated patients with Gaucher disease.从两名无关的戈谢病患者中获得两条诱导多能干细胞系。
Stem Cell Res. 2019 Mar;35:101336. doi: 10.1016/j.scr.2018.10.021. Epub 2018 Nov 18.
5
New macrophage models of Gaucher disease offer new tools for drug development.戈谢病新的巨噬细胞模型为药物研发提供了新工具。
Macrophage (Houst). 2015;2(1):e712.
6
Induced pluripotent stem cell models of lysosomal storage disorders.溶酶体贮积症的诱导多能干细胞模型。
Dis Model Mech. 2017 Jun 1;10(6):691-704. doi: 10.1242/dmm.029009.
7
In Pursuit of Authenticity: Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Clinical Applications.追求真实性：用于临床应用的诱导多能干细胞衍生视网膜色素上皮细胞
Stem Cells Transl Med. 2016 Nov;5(11):1562-1574. doi: 10.5966/sctm.2016-0037. Epub 2016 Jul 11.
8
Engineering-derived approaches for iPSC preparation, expansion, differentiation and applications.工程衍生方法用于 iPSC 的制备、扩增、分化及应用。
Biofabrication. 2017 Jul 31;9(3):032001. doi: 10.1088/1758-5090/aa7e9a.
9
Immunogenicity and functional evaluation of iPSC-derived organs for transplantation.用于移植的诱导多能干细胞衍生器官的免疫原性和功能评估。
Cell Discov. 2015 Jul 7;1:15015. doi: 10.1038/celldisc.2015.15. eCollection 2015.
10
Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury.诱导多能干细胞来源与骨髓来源的间充质基质细胞在小鼠角膜损伤模型中的抗炎作用比较。
Cytotherapy. 2017 Jan;19(1):28-35. doi: 10.1016/j.jcyt.2016.10.007. Epub 2016 Nov 10.
引用本文的文献
1
CRISPR/Cas9 Editing for Gaucher Disease Modelling.CRISPR/Cas9 编辑用于戈谢病建模。
Int J Mol Sci. 2020 May 5;21(9):3268. doi: 10.3390/ijms21093268.
2
Lysosomal storage diseases.溶酶体贮积症。
Nat Rev Dis Primers. 2018 Oct 1;4(1):27. doi: 10.1038/s41572-018-0025-4.
本文引用的文献
1
Gaucher Disease-Induced Pluripotent Stem Cells Display Decreased Erythroid Potential and Aberrant Myelopoiesis.戈谢病诱导的多能干细胞表现出红系分化潜能降低和异常髓系造血。
Stem Cells Transl Med. 2015 Aug;4(8):878-86. doi: 10.5966/sctm.2014-0213. Epub 2015 Jun 10.
2
Mechanisms of Gaucher disease pathogenesis.戈谢病发病机制。
Ann Transl Med. 2015 May;3(Suppl 1):S1. doi: 10.3978/j.issn.2305-5839.2015.03.42.
3
iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.诱导多能干细胞衍生的多巴胺神经元揭示了患帕金森病的同卵双胞胎之间的差异。
Cell Rep. 2014 Nov 20;9(4):1173-82. doi: 10.1016/j.celrep.2014.10.023. Epub 2014 Nov 6.
4
Reply: Lysosomal dysfunction in Parkinson's disease.回复：帕金森病中的溶酶体功能障碍。
Brain. 2015 Apr;138(Pt 4):e340. doi: 10.1093/brain/awu268. Epub 2014 Sep 11.
5
Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs.用于评估疾病发病机制和候选药物的戈谢病巨噬细胞模型。
Sci Transl Med. 2014 Jun 11;6(240):240ra73. doi: 10.1126/scitranslmed.3008659.
6
Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.戈谢病伴 GBA 杂合子的阿什肯纳兹犹太裔帕金森病风险比较。
JAMA Neurol. 2014 Jun;71(6):752-7. doi: 10.1001/jamaneurol.2014.313.
7
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells.氨溴索可改善葡萄糖脑苷脂酶突变相关帕金森病细胞的溶酶体生化特性。
Brain. 2014 May;137(Pt 5):1481-95. doi: 10.1093/brain/awu020. Epub 2014 Feb 25.
8
Glucocerebrosidase is shaking up the synucleinopathies.葡萄糖脑苷脂酶正在颠覆神经核蛋白病领域。
Brain. 2014 May;137(Pt 5):1304-22. doi: 10.1093/brain/awu002. Epub 2014 Feb 14.
9
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.葡萄糖脑苷脂酶减少与散发性帕金森病中α-突触核蛋白的增加有关。
Brain. 2014 Mar;137(Pt 3):834-48. doi: 10.1093/brain/awt367. Epub 2014 Jan 28.
10
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains.帕金森病脑黑质中葡萄糖脑苷脂酶缺乏。
Ann Neurol. 2012 Sep;72(3):455-63. doi: 10.1002/ana.23614.
Zotero 插件